[Federal Register Volume 71, Number 194 (Friday, October 6, 2006)]
[Notices]
[Page 59124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-8519]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the sixth 
meeting of the National Science Advisory Board for Biosecurity (NSABB).
    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
Federal oversight of dual-use research, defined as biological research 
with legitimate scientific proposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open to the public; however, pre-registration 
is strongly recommended due to space limitations. Persons planning to 
attend should register online at http://www.biosecurityboard.gov/meetings.asp or by calling Capital Consulting Corporation (Contact: 
Saundra M. Bromberg) at 301-468-6004, ext. 406. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate 
these requirements upon registration.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: October 25, 2006.
    Open: 12 p.m to 5 p.m.
    Agenda: Presentations and discussions regarding: (1) Draft 
recommendations of the NSABB Working Group on Synthetic Genomics for 
addressing biosecurity concerns raised by the ability to synthesize 
select agents de novo; (2) draft statement by the Communications 
Working Group on the necessity of open scientific communication; (3) 
public comments; and (4) other business of the Board.
    Place: The National Institutes of Health, 31 Center Drive, 
Building 31, 6C--Room 10, Bethesda, Maryland 20892.
    Contact Persons: Laurie Lewallen, NSABB Program Assistant, NIH 
Office of Biotechnology Activities, 6705 Rockledge Drive, Bethesda, 
Maryland 20892. (301) 496-9838.
    This meeting will also be webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the webcast and pre-registration, will be available at http://www.biosecurityboard.gov/meetings.asp.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization represented and a 
short description of the oral presentation. Only one representative 
of an organization may be allowed to present oral comments. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee. All written comments must be received by October 16, 2006 
and should be sent via e-mail to <a href="/cdn-cgi/l/email-protection#f69885979494b69992d8989f9ed8919980"><span class="__cf_email__" data-cfemail="bcd2cfdddedefcd3d892d2d5d492dbd3ca">[email protected]</span></a> with ``NSABB 
Public Comment'' as the subject line or by regular mail to 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Laurie 
Lewallen. The statement should include the name, address, telephone 
number and, when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on Campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: September 29, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8519 Filed 10-5-06; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>